中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
15期
12-13,15
,共3页
盐酸肾上腺素%布地奈德%小儿急性感染性喉炎
鹽痠腎上腺素%佈地奈德%小兒急性感染性喉炎
염산신상선소%포지내덕%소인급성감염성후염
Epinephrine hydrochloride%Budesonide%Children's acute infectious laryngitis
目的:探讨盐酸肾上腺素联合布地奈德雾化吸入治疗小儿急性感染性喉炎的临床效果。方法:将58例急性感染性喉炎患儿按不同治疗方法分为实验组(30例,常规治疗+盐酸肾上腺素联合布地奈德雾化吸入)和对照组(28例,常规治疗+静脉滴注地塞米松),对两组患儿的治疗效果进行综合比较。结果:(1)治疗12h 后,实验组患儿的治疗总有效率为96.67%,明显高于对照组(75.00%)(P<0.05);(2)实验组患儿声嘶、呼吸困难、喉鸣音等症状体征消失时间明显少于对照组(P<0.01)。结论:盐酸肾上腺素联合布地奈德雾化吸入治疗小儿急性感染性喉炎效果显著,值得临床推广应用。
目的:探討鹽痠腎上腺素聯閤佈地奈德霧化吸入治療小兒急性感染性喉炎的臨床效果。方法:將58例急性感染性喉炎患兒按不同治療方法分為實驗組(30例,常規治療+鹽痠腎上腺素聯閤佈地奈德霧化吸入)和對照組(28例,常規治療+靜脈滴註地塞米鬆),對兩組患兒的治療效果進行綜閤比較。結果:(1)治療12h 後,實驗組患兒的治療總有效率為96.67%,明顯高于對照組(75.00%)(P<0.05);(2)實驗組患兒聲嘶、呼吸睏難、喉鳴音等癥狀體徵消失時間明顯少于對照組(P<0.01)。結論:鹽痠腎上腺素聯閤佈地奈德霧化吸入治療小兒急性感染性喉炎效果顯著,值得臨床推廣應用。
목적:탐토염산신상선소연합포지내덕무화흡입치료소인급성감염성후염적림상효과。방법:장58례급성감염성후염환인안불동치료방법분위실험조(30례,상규치료+염산신상선소연합포지내덕무화흡입)화대조조(28례,상규치료+정맥적주지새미송),대량조환인적치료효과진행종합비교。결과:(1)치료12h 후,실험조환인적치료총유효솔위96.67%,명현고우대조조(75.00%)(P<0.05);(2)실험조환인성시、호흡곤난、후명음등증상체정소실시간명현소우대조조(P<0.01)。결론:염산신상선소연합포지내덕무화흡입치료소인급성감염성후염효과현저,치득림상추엄응용。
Objective:To investigate clinical effects of Epinephrine hydrochloride combined with Budesonide for atomization in-halation in treatment of children's acute infectious laryngitis. Methods:58 children with acute infectious laryngitis were divided into ex-perimental group (30 cases, conventional therapy + Epinephrine hydrochloride and Budesonide for atomization inhalation) and control group (28 cases, conventional therapy + Dexamethasone through intravenous drip). The efficacies of the two groups were compared. Results: (1) 12h after the treatment, the total effective rate of experimental group (96. 67% ) was significantly higher than that of control group (75. 00% ) (P<0. 05). (2)The disappearance time of hoarseness, dyspnea, and throat beep in experimental group was less than that in control group (P<0. 01). Conclusions: There are significant effects of Epinephrine hydrochloride combined with Budesonide for atomization inhalation in the treatment of children's acute infectious laryngitis, which is worthy of clinical promotion and application.